Surrozen Operating Inc. Secures Anti-Frizzled Antibody Patent

Tue, 21 Apr 2026 14:20:15 +0000
Intellectual Property

The USPTO granted Patent US12606629B2 to Surrozen Operating, Inc. on April 21, 2026. The patent covers monospecific anti-Frizzled monoclonal antibodies and related compositions for therapeutic applications. The application, filed July 2, 2020, received 10 claims under CPC classifications including C07K 16/2863.